Novel methotrexate soft nanocarrier/fractional erbium YAG laser combination for clinical treatment of plaque psoriasis

References

• Goff KL, Karimkhani C, Boyers LN, et al. The global burden of psoriatic skin disease. Br J Dermatol. 2015;172:1665–1668.
   PubMed Web of Science ®Google Scholar
• Gupta R, Debbaneh MG, Liao W. Genetic epidemiology of psoriasis. Curr Derm Rep. 2014;3:61–78.
   PubMedGoogle Scholar
• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.
   PubMed Web of Science ®Google Scholar
• Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64:18–23.
   Web of Science ®Google Scholar
• Abdelgawad R, Nasr M, Hamza MY, et al. Topical and systemic dermal carriers for psoriasis. Int J Curr Pharm Res. 2016;8:4–9.
   Google Scholar
• Carretero G, Puig L, Dehesa L, et al. Guidelines on the use of methotrexate in psoriasis. Actas Dermosifiliogr. 2010;101:600–613.
   PubMedGoogle Scholar
• Elango T, Dayalan H, Gnanaraj P, et al. Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients. Clin Exp Med. 2014;14:431–437.
   PubMed Web of Science ®Google Scholar
• Cronstein BN. The mechanism of action of methotrexate. Rheum Dis Clin North Am. 1997;23:739–755.
   PubMed Web of Science ®Google Scholar
• Festugato M. Adenosine: an endogenous mediator in the pathogenesis of psoriasis. An Bras Dermatol. 2015;90:862–867.
   PubMed Web of Science ®Google Scholar
• Ali MF, Salah M, Rafea M, et al. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting. Med Sci Monit. 2008; 14:166–174.
   Web of Science ®Google Scholar
• Weinstein GD, McCullough JL, Olsen E. Topical methotrexate therapy for psoriasis. Arch Dermatol. 1989;125:227–230.
   PubMed Web of Science ®Google Scholar
• Wong TW, Zhao YL, Sen A, et al. Pilot study of topical delivery of methotrexate by electroporation. Br J Dermatol. 2005;152:524–530.
   PubMed Web of Science ®Google Scholar
• Forster B, Klein A, Szeimies RM, et al. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: Continuous versus fractional ablation. Exp Dermatol. 2010;19:806–812.
   PubMed Web of Science ®Google Scholar
• Paasch U, Haedersdal M. Laser systems for ablative fractional resurfacing. Expert Rev Med Devices. 2011;8:67–83.
   PubMed Web of Science ®Google Scholar
• Abdelgawad R, Nasr M, Moftah NH, et al. Phospholipid membrane tubulation using ceramide doping “cerosomes”: characterization and clinical application in psoriasis treatment. Eur J Pharm Sci. 2017;101:258–268.
   PubMed Web of Science ®Google Scholar
• Fadel M, Samy N, Nasr M, et al. Topical colloidal indocyanine green-mediated photodynamic therapy for treatment of basal cell carcinoma. Pharm Dev Technol. 2017;22:545–550.
   PubMed Web of Science ®Google Scholar
• Bsieso EA, Nasr M, Moftah NH, et al. Could nanovesicles containing a penetration enhancer clinically improve the therapeutic outcome in skin fungal diseases? Nanomedicine. 2015;10:2017–2031.
   PubMed Web of Science ®Google Scholar
• Bseiso EA, Nasr M, Sammour OA, et al. Novel nail penetration enhancer vesicles “nPEVs” for treatment of onychomycosis. Drug Deliv. 2016;23:2813–2819.
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. Nanotechnological approaches for the effective management of psoriasis. Artif Cells Nanomed Biotechnol. 2017;44:1371–1382.
   Web of Science ®Google Scholar
• Parnami N, Garg T, Rath G, et al. Development and characterization of nanocarriers for topical treatment of psoriasis by using combination therapy. Artif Cells Nanomed Biotechnol. 2014;42:406–412.
   PubMed Web of Science ®Google Scholar
• Agrawal U, Gupta M, Vyas SP. Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif Cells Nanomed Biotechnol. 2015;43:33–39.
   PubMed Web of Science ®Google Scholar
• Hathout RM, Nasr M. Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies. Colloids Surf B Biointerfaces. 2013;110:254–260.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modelling. Drug Dev Ind Pharm. 2016;42:636–643.
   PubMed Web of Science ®Google Scholar
• Nasr M, Abdel-Hamid S, Moftah NH, et al. Jojoba oil soft colloidal nanocarrier of a synthetic retinoid: preparation, characterization and clinical efficacy in psoriatic patients. Curr Drug Deliv. 2017;14:426–432.
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. Severe psoriasis-oral therapy with a new retinoid. Dermatologica. 1978;157:238–244.
   PubMedGoogle Scholar
• Langley RG, Ellis CN. Evaluating psoriasis with psoriasis area and severity index, psoriasis global assessment, and lattice system physician’s global assessment. J Am Acad Dermatol. 2004;51:563–569.
   PubMed Web of Science ®Google Scholar
• Sklar LR, Burnett CT, Waibel JS, et al. Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med. 2014;46:249–262.
   PubMed Web of Science ®Google Scholar